Chief Operating Officer · Solid Biosciences Inc. (SLDB)

Joel Schneider

FY2021 is the first fiscal year CompBrief holds for Joel Schneider as a named executive officer of Solid Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,702,761

Salary $423,265Stock awards $0Bonus $118,320

3rd of 3 named executive officers at Solid Biosciences by FY2021 total.

3 named officers on file for Solid Biosciences, FY2021

Joel Schneider’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Solid Biosciences’s whole pay program stands against its peers

  • Solid Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SLDB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A).

Free

Get Joel Schneider’s full pay file as a PDF — free

More than this page: up to 10 years of Joel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Joel Schneider compensation by year

Solid Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Solid Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$423,265
Bonus$118,320
Stock awards$0
Option awards$1,155,050
Non-equity incentive$0
Pension and deferred compensation$0
All other$6,126
Total$1,702,761

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Solid Biosciences Inc. DEF 14A filed April 28, 2022, accession 0001193125-22-125475, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Solid Biosciences Inc. filed document, accession 0001193125-22-125475. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU37,500$65,625—
RSU37,500$65,625—
Option30,000—$22.93
Option35,250—$3.47
Option15,000—$10.72
Option26,420—$26.23
Option175,000—$6.80

Per the Outstanding Equity Awards at Fiscal Year-End table in Solid Biosciences Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Solid Biosciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Ilan GanotPresident and Chief Executive Officer$3,293,809
Erin BrennanChief Legal Officer$2,878,244
Joel Schneider · this pageChief Operating Officer$1,702,761

The full Solid Biosciences compensation record

free company brief

This page is one person within Solid Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Solid Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Joel Schneider's compensation dossier · One-time report. No refunds.